PATENT CLAIM ANALYSIS

Application Number: 16345132
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-09
Patent Classification: ["424", "489000"]

Abstract:
The present disclosure discloses compositions, and methods of making and using nanoparticles to treat multiple myeloma.

Claim (Index 29):
The method of  claim 26 , wherein BTZ from the anti-CD38 BTZ loaded chitosan nanoparticles is specifically released in the acidic tumor environment.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 100.0
- Lexical Diversity: 1.05882
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12322443', '12928878', '12807562', '15189577', '12321113']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6916380857296054
- 35 USC 102 Novelty (BERT): 0.5148464352867591
- Combined Prediction Score: 0.6739589206853207
- Mean Citation Score: 207.392196
- Max Citation Score: 218.70247
- Similarity Product: 118.47387973783196

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test